Search for: "GALDERMA LABORATORIES INC" Results 21 - 30 of 30
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Aug 2010, 12:37 am by Kelly
(Patent Docs) Clobex (Clobetasol propionate) – US: Patent infringement complaint filed following a Paragraph IV certification: Galderma Laboratories, L.P. et al. v. [read post]
8 Jul 2010, 7:38 am by Andrew Russell
On June 28th, Magistrate Judge Stark issued an order granting Mylan Pharmaceuticals, Inc.'s motion to amend its infringement response to include an allegation of unenforceability due to inequitable conduct, based on plaintiff Galderma Laboratories' failure to disclose an allegedly material FDA action during prosecution. [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
17 Feb 2010, 8:00 am by Karen E. Keller
(patent infringement) 1/21: Galderma Laboratories LP, Galderma SA and Galderma Research and Development SNC v. [read post]
9 Oct 2009, 9:11 am
(patent infringement) 9/18: Research Foundation of State University of New York, New York University, Galderma Laboratories, Galderma Laboratories LP v. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram) – US: Caraco… [read post]